Keyphrases
CD4+ T Cells
100%
Cancer Immunotherapy
100%
Activin
100%
Activin Receptor
100%
ITreg
66%
CD4 Cells
50%
Nave
33%
Treg
33%
Forkhead Box P3 (FOXP3)
33%
In Cancer
16%
Cancer Patients
16%
Reduced Expression
16%
Immune Cells
16%
Healthy Controls
16%
Tumor Cells
16%
Transforming Growth Factor-β
16%
Immune System
16%
In Vitro Study
16%
PCR Analysis
16%
Endocrine System
16%
Neuroendocrine-immune System
16%
Tumor Burden
16%
Disease-specific
16%
Tumor Microenvironment
16%
Immune Parameters
16%
Culture Media
16%
Tumor Progression
16%
Tumor-bearing Mice
16%
Specific Strategies
16%
Induced Regulatory T Cells
16%
Treg Suppression
16%
ActRIIB
16%
Suppression Assay
16%
TGF-β Superfamily
16%
Biochemistry, Genetics and Molecular Biology
T Cell
100%
CD4
100%
Cancer Immunotherapy
100%
Activin
100%
Activin Receptor
100%
Mouse
66%
Regulatory T Cell
66%
Transforming Growth Factor Beta
33%
Immunocompetent Cell
33%
Tumor Progression
16%
Wild Type
16%
In Vitro Study
16%
Quantitative Reverse Transcription Polymerase Chain Reaction
16%
Tumor Volume
16%
Medicine and Dentistry
T-Helper Cell
100%
Cancer Immunotherapy
100%
Activin Receptor
100%
Activin
100%
Malignant Neoplasm
50%
Neoplasm
33%
In Vitro
33%
Transforming Growth Factor Beta
33%
Immunocompetent Cell
33%
Disease
16%
Quantitative Reverse Transcription Polymerase Chain Reaction
16%
Tumor Cell
16%
Tumor Progression
16%
Immune System
16%
Immunosuppressive Drug
16%
Tumor Microenvironment
16%
Regulatory T Cell
16%
Endocrine System
16%
Immunology and Microbiology
T-Helper Cell
100%
Cancer Immunotherapy
100%
Activin
100%
Mouse
44%
Regulatory T Cell
44%
CD4
33%
Immunocompetent Cell
22%
Transforming Growth Factor Beta
22%
Quantitative Reverse Transcription Polymerase Chain Reaction
11%
Wild Type
11%
Tumor Cell
11%
Immune System
11%
Blood Plasma
11%
Tumor Volume
11%
Immunosuppressive Drug
11%
Endocrine System
11%